Doxorubicin
- PDF / 168,873 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 19 Downloads / 169 Views
1 S
Cardiotoxicity: case report In a study conducted between January 2000 and December 2015, a female patient [age not stated] was described, who developed cardiotoxicity during treatment with doxorubicin for breast cancer. The female patient, who had diabetes and breast cancer, underwent breast surgery. After the surgery, she received adjuvant therapy with doxorubicin [route and dosage not stated]. Subsequently, she developed doxorubicin-induced cardiotoxicity [duration of treatment to reaction onset and outcome not stated]. Park B, et al. Genome-wide association study of genetic variants related to anthracycline-induced cardiotoxicity in early breast cancer. Cancer Science 111: 2579-2587, No. 7, 803500567 Jul 2020. Available from: URL: http://doi.org/10.1111/cas.14446
0114-9954/20/1821-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 12 Sep 2020 No. 1821
Data Loading...
